Sign up to save your podcasts
Or
Share Episode: 48 - A Conversation with Peter Tessier: Classifying Antibodies to Assess Biologics Developability Features Early in the Discovery Process
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode: 48 - A Conversation with Peter Tessier: Classifying Antibodies to Assess Biologics Developability Features Early in the Discovery Process
In this month’s episode of the Chain, guest Peter Tessier, Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the University of Michigan, speaks with moderator Tariq Ghayur, scientific advisor and entrepreneur in residence at FairJourney Biologics, about expediting the developability of antibodies. He discusses the characteristics that best predict a molecule’s drug-like properties, the different assays used for various intended outcomes, and why every scientist must assess the “greatest potential impact” before embarking on a new experiment. Tessier also talks about the core traditions that help him lead students in the lab while fostering a learning environment of ownership, integrity, and self-motivation. Last, he shares his predictions on how computational data will advance antibody discovery and developability in the future.
View all episodes
By Cambridge Healthtech Institute
4.8
2525 ratings
In this month’s episode of the Chain, guest Peter Tessier, Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the University of Michigan, speaks with moderator Tariq Ghayur, scientific advisor and entrepreneur in residence at FairJourney Biologics, about expediting the developability of antibodies. He discusses the characteristics that best predict a molecule’s drug-like properties, the different assays used for various intended outcomes, and why every scientist must assess the “greatest potential impact” before embarking on a new experiment. Tessier also talks about the core traditions that help him lead students in the lab while fostering a learning environment of ownership, integrity, and self-motivation. Last, he shares his predictions on how computational data will advance antibody discovery and developability in the future.
More shows like The Chain: Protein Engineering Podcast
View all
Radiolab
43,831 Listeners
Freakonomics Radio
32,011 Listeners
Planet Money
30,711 Listeners
HBR IdeaCast
1,834 Listeners
The Daily
112,426 Listeners
The Long Run with Luke Timmerman
125 Listeners
The Indicator from Planet Money
9,530 Listeners
The Readout Loud
320 Listeners
The Journal.
6,094 Listeners
Fiction - Comedy Fiction
6,444 Listeners
Consider This from NPR
6,394 Listeners
BioCentury This Week
34 Listeners
Hard Fork
5,520 Listeners
Biotech Hangout
18 Listeners
The Top Line
13 Listeners